Developing new methods to modify important drug components
New Chemical Process to Selectively Functionalize Pyridines, Diazines and Pharmaceuticals
This study is looking at new ways to change certain chemicals found in approved medications to make them work better in the body, which could lead to more effective treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project ID | NIH-10900613 on NIH RePORTER |
What this research studies
This research focuses on creating innovative chemical processes to modify pyridine and diazine compounds, which are commonly found in FDA-approved medications. By introducing new synthetic strategies, the project aims to enhance the ability to add various functional groups to these compounds, improving their interaction with biological targets. The research will explore different approaches, including the use of phosphonium salts and direct coupling reactions, to facilitate these modifications. This could lead to more effective drugs by optimizing their chemical properties and interactions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may benefit from new drug therapies targeting conditions treated by medications containing pyridine and diazine structures.
Not a fit: Patients who are not affected by conditions treated by existing or potential new drugs utilizing these chemical modifications may not receive any benefit.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective pharmaceuticals with improved efficacy and safety profiles.
How similar studies have performed: Other research has shown promise in developing new synthetic strategies for drug modification, indicating that this approach could yield significant advancements.
Where this research is happening
Fort Collins, United States
- Colorado State University — Fort Collins, United States (Active)
Researchers
- Principal investigator: Mcnally, Andrew — Colorado State University
- Study coordinator: Mcnally, Andrew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.